Millions of dollars are again being spent to scare the public away from taking effective level of vitamin D3 supplements, that can block the development of invasive breast cancer in U.S. women.
Last summer Big Pharma sponsored a Vitamin D3 report by experts, most of whom currently received significant income from pharmaceutical companies, that ignored twenty years of solid research on the many benefits enjoyed by Americans taking much much higher levels of vitamin D3. Using the Institute of Medicine, a pharmaceutical-industry funded organization, the July 2010 report urged Americans to limit their intake of Vitamin D3 to 1,000 IUs or less per day.
Now someone is paying big bucks to publicize a small mouse study out of Georgetown University Hospital, that mentions how high levels of vitamin D3… although clearly helpful in stopping most types of breast cancer, was not helpful for skinny mice who were “pre-destined” to develop one type of estrogen negative breast cancer. This.. after feeding the poor mice 15,000 IUs or more of vitamin D3 a day!
It will be important to see what leading Vitamin D3 researcher at University of California’s Moores Cancer Center or their education organization Grassroots Health, or the Vitamin D Council, or researchers at Sunlight, Nutrition and Health Research or the well-respected Vitamin D researcher, Dr Michael Holick, at Boston University has to say about this latest publicity effort to limit Americans’ intake of this inexpensive food supplement that can help stop breast and colon cancer and many other conditions before they start. See Dr Cedric Garland’s video on how higher levels of vitamin D3 protects against these types of cancers in humans.
Remember… as more and more Americans use adequate levels of inexpensive Vitamin D3 supplements to protect ourselves from breast and colon cancers, the pharmaceutical companies lose billions of dollars each year in chemotherapy sales.